Actively Recruiting
Evaluating Myo-Inositol and Selenium Supplementation in Patients with Indeterminate Thyroid Nodules TIR3A
Led by Regina Elena Cancer Institute · Updated on 2026-08-26
30
Participants Needed
1
Research Sites
28 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to evaluate the effects of myo-inositol and selenium supplementation on indeterminate thyroid nodules classified as TIR3A, which carry a low risk of malignancy below 10%. The study focuses on patients with thyroid nodules that require careful clinical and ultrasound follow-up due to their uncertain cancer risk. Researchers seek to assess whether this supplement can reduce nodule size, stiffness, and cellular proliferation compared to untreated patients. Participants are randomly assigned to either receive a daily supplement containing 600 mg of myo-inositol and 83 mcg of selenium for six months or to a control group with no intervention. The study investigates changes in nodule characteristics using ultrasound and elastosonography, as well as cellular markers through immunocytochemical analysis. The treatment period lasts six months, and comparisons are made between treated and untreated groups. During the study, participants undergo evaluations including ultrasound assessments to measure nodule size and elasticity, laboratory tests for thyroid hormones and antibodies, and immunocytochemical tests for proliferation markers. Researchers monitor differences in thyroid function, antibody levels, and nodule characteristics over six months. The primary outcome is the change in elastosonography results, with secondary outcomes including nodule growth inhibition and hormone level variations. Participants safety and response to supplementation are observed throughout the study duration.
CONDITIONS
Brief Title
Myo-inositol and Selenium in Indeterminate Thyroid Nodules (TIR3a)
Research Team
M
Marialuisa Appetecchia, MD
G
Giulia Puliani, MD, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here